Translational Cancer Research on Urogenital Malignancies

Nanoparticle Drug Delivery Systems

The approach here is to use mesoporous silica nanoparticles that are loaded with drug and decorated with prostate cancer specific targeting moieties to “attack” prostate cancer. We collaborate heavily with Dr. Jason Townson, Dr. Yu-Shen Lin, and Dr. Jeffrey Brinker to accomplish these goals. Not a lot to disclose right now – PCT to be filed!